Literature DB >> 30778638

Combination of brachytherapy and chemotherapy not superior to pelvic radiotherapy according to GOG-249.

Alexandros Papachristofilou1, Tobias Finazzi2.   

Abstract

Mesh：

Year:  2019        PMID： 30778638     DOI： 10.1007/s00066-019-01439-4

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  2 in total

Review 1.  Evolution of adjuvant treatment in endometrial cancer-no evidence and new questions?

Authors:  S Marnitz; C Köhler; N Gharbi; S Kunze; K Jablonska; J Herter
Journal:  Strahlenther Onkol       Date:  2018-08-15       Impact factor: 3.621

2.  Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.

Authors:  Stephanie M de Boer; Melanie E Powell; Linda Mileshkin; Dionyssios Katsaros; Paul Bessette; Christine Haie-Meder; Petronella B Ottevanger; Jonathan A Ledermann; Pearly Khaw; Alessandro Colombo; Anthony Fyles; Marie-Helene Baron; Ina M Jürgenliemk-Schulz; Henry C Kitchener; Hans W Nijman; Godfrey Wilson; Susan Brooks; Silvestro Carinelli; Diane Provencher; Chantal Hanzen; Ludy C H W Lutgens; Vincent T H B M Smit; Naveena Singh; Viet Do; Romerai D'Amico; Remi A Nout; Amanda Feeney; Karen W Verhoeven-Adema; Hein Putter; Carien L Creutzberg
Journal:  Lancet Oncol       Date:  2018-02-12       Impact factor: 41.316
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.